Preparedness must to face earthquake aftermath: Speakers

Earthquake preparedness (both institutional and community level) techniques help save lives and minimize destructions, they said.

Failure to ensure preparedness may culminate in huge loss of lives and properties, they mentioned at a roundtable at the conference room of East West Media Group Limited at Bashundhara in the city.

BRAC and Bangla daily Kalerkantho jointly organized the event.

State Minister for Disaster Management and Relief Dr. Enamur Rahman attended as the chief guest, while Imdadul Haque Milon, editor of Kalerkantho, moderated it.

Md. Mohsin, Secretary of Disaster Management and Relief Ministry; Brigadier General Mohammad Sajjad Hussain, Director General of Fire Service and Civil Defence; Shamsuddin Ahmed, Director General of Bangladesh Meteorological Department (BMD); Sajedul Hasan, Director of Humanitarian Programme of BRAC; Dr. A.S.M Maksud Kamal, Pro-Vice Chancellor of University of Dhaka; among others, spoke.

To follow the Building Code while constructing new building is also helpful in minimizing the risks. It will not only reduce the chance of building collapse but also save people’s lives, they said.

Dr. Enamur Rahman said the government is going to sign agreement with JICA soon for combating earthquake .

The government will work on different issues, including ensuring construction of new buildings following the National Building Code as per the agreement, he said.

The minister said the government as part of earthquake preparedness is giving emphasis on buying modern equipment. Hence, he said, the Prime Minister has allocated Tk. 2,300 crore.

Sajedul Hasan called for imparting proper and continued training for volunteers who work under the disaster management programmes of the government.

If it is ensured, the volunteers will be able to play an important role in rescue operations during any disaster, he said.

The discussants placed a number of recommendations including raising mass awareness, purchasing modern equipment for facilitating post-disaster rescue operation; arranging proper training for volunteers.

Source: United News of Bangladesh

International vaccine institute to be set up in Bangladesh: Hasina

Prime Minister Sheikh Hasina on Wednesday said the government is going to set up an international vaccine institute to produce vaccines, including the Covid-19 ones, in Bangladesh.

Sheikh Hasina said this in Parliament while replying to a tabled question from Awami League MP Ahasanul Islam Titu (Tangail-6).

She said the government will sign an agreement with South Korea to set up the vaccine institute and the issues relating to ratification, accession and approval of the agreement by the Cabinet are under process.

The Prime Minister said the government has taken an initiative to produce Covid-19 vaccines in the country alongside collection from foreign sources to check the Covid-19 pandemic in the country.

Hasina said government-to government (G2G) negotiations are underway with the countries that have developed vaccines for transferring technology to this end.

She said the capacity of three firms — Incepta Pharmaceuticals, Popular Pharmaceuticals and Healthcare Pharmaceuticals — have already been assessed over the production of Covid-19 vaccines.

Globe Biotech Ltd is working on a Covid vaccine. “The vaccine developed by Globe Biotech is now at the trial stage,” she said.

Replying to another question from Jatiya Party MP Fakhrul Imam, the Prime Minister said the government has so far approved the emergency use of five vaccines for their import.

The vaccines are Oxford-AstraZeneca, Sinopharm (China), Sputnik-V (Russia), Pfizer-BioNTech (USA/Germany) and Crona Vac (China).

She said Bangladesh has so far collected a total of 1,08,0620 (1.08 crore) shots of Covid vaccines from different foreign sources. Of these, 1.02 crore shots, including the gifted ones, came from India, while 5 lakh from Sinopharm and 1,0620 doses from Pfizer.

As of June 5 last, 58,22,177 people were given the first doses of vaccines, while 42,09,510 given the second doses, said the Prime Minister.

Source: United News of Bangladesh

Italy launches production of Sputnik V Covid-19 jab’s test batch

Italy has launched the production of the first test batch of the Russian Sputnik V vaccine, the Swiss-Italian company Adienne Pharma & Biotech’s press service told TASS on Wednesday.

“We have launched the production of a test batch, which will be subjected to an internal review for safety and compliance,” a spokesperson said. The work is being carried out in close contact with the drug’s developer, he noted. After the internal assessment, the company will produce a batch to submit all necessary documents to the competent sanitary authorities so that the jab can be approved for sale. Meanwhile, the company did not mention any specific date.

In late March, the Russian Direct Investment Fund agreed on launching the Sputnik V jab’s production at the Swiss-Italian company Adienne Pharma & Biotech. Earlier, the company’s CEO Antonio Di Naro told TASS that the vaccine would enter the market as early as in late 2021 after passing all the necessary certification procedures.

Russia’s Sputnik V jab has not been approved by the European Medicines Agency (EMA) yet. On March 4, the EMA launched the rolling review of the vaccine. Recently, the experts have completed an inspection of Russia’s production sites, and now some additional documents are underway. If no such permission for Sputnik V’s sales in Europe is issued, the batches produced in Italy can be sold to the countries where the drug is approved. There are more than 60 of them, the Swiss-Italian company said.

Source: United News of Bangladesh

Govt. assures vaccination for RMG workers on priority basis

Health Minister Zahid Maleque has assured the Bangladesh Garment Manufacturers and Exporters Association (BGMEA) of vaccinating garment workers on priority basis after sufficient vaccine doses are available in the country.

The assurance came after a delegation of BGMEA led by President Faruque Hassan met with the health minister and made the request to him for ensuring vaccines for the RMG workers on priority basis considering them as front liners as they have been doing their jobs amid the pandemic to protect the economy of the country.

The BGMEA president also requested for ensuring Covid vaccines for the officials of foreign apparel brands and buyers working in Bangladesh on priority basis and the minister said it would be considered.

The BGMEA delegation included First Vice President Syed Nazrul Islam, Vice President Md. Shahidullah Azim and Vice President Miran Ali.

Faruque Hassan sought the assistance of the Health Ministry with regard to payment of more than 36 crore taka to some garment factories which supplied personal protective equipment (PPE) to the Central Medical Stores Depot (CMSD) which remained due.

The health minister said the ministry would take necessary steps to resolve the issue.

Lokman Hossain Miah, secretary to the Health Services Division under the health ministry and Prof Dr ABM Khurshid Alam, Director General of the Directorate General of Health Services (DGHS) were also present at the meeting.

Source: United News of Bangladesh

BNP smells a rat in Pori Moni incident

BNP secretary general Mirza Fakhrul Islam Alamgir on Wednesday alleged that actress Pori Moni’s issue was brought to the limelight to divert people’s attention to a different direction from Khaleda Zia’s illness and the government’s failure to tackle the Covid situation.

Speaking at a roundtable discussion, he also questioned the seven-day remand of businessman Nasir U Mahmud in a case filed under the Narcotics Control Act.

“The main job of the current government is to deceive people and mislead them. Our journalist brothers are now very active over the Pori Moni issue. Who is Pori Moni? Can’t we understand it’s again a matter of diversion and misleading people?” the BNP leader said.

He said, “When there’re talks over Khaleda Zia’s illness and her release, the country’s democratic situation and the Health Ministry’s extreme failure, and when the Covid cases keep surging, this issue has been brought to the forefront.”

Fakhrul said it is only possible for Awami League to deceive people and play games with them. “They’re suppressing the entire nation resorting to this tactic.”

BNP’s national committee on celebrating the Golden Jubilee of the country’s independence arranged the programme at the Jatiya Press Club, marking the shutdown of all newspapers except four state-run ones on 16 June 1975.

On Monday, Nasiruddin Mahmud, former president of Uttara Club Limited, and four others were arrested from a Uttara flat in the capital following a case filed over his reported attempt to rape and kill actress Pori Moni.

Pori Moni, in her verified Facebook page, sought justice from Prime Minister Sheikh Hasina. “I’ve been physically assaulted and they even attempted to rape and kill me. I want justice,” she stated in her post.

Meanwhile, a Dhaka court placed Nasir and another co-accused Tuhin Siddique Omi on seven-day remand each in a case filed under the Narcotics Control Act.

Fakhrul said people have no security in the country as law enforcers are suddenly picking up people in different cases, including false ones.

“I don’t know how much of this incident (Pori Moni’s) is true and false. But seeing yesterday’s incident, I’ve got an impression that everything is now possible in this country. The case was filed for attempting to rape and kill. But he (Nasir) was remanded in a narcotics case,” he said.

Fakhrul also said he could not understand the reason behind placing businessman Nasir on the remand in the narcotic case when he does not own the house from where the liquor and drugs were recovered.

“Many questions have now arisen. Whether the powerful people and ruling party can do whatever they want. Whether the administration can pick up any one as per their whims and can defame and ruin his/her social dignity and family reputation in this way,” he questioned.

Source: United News of Bangladesh

Alarming Covid surge in Bangladesh, 60 more die

Bangladesh recorded 60 Covid-related deaths and 3,956 new cases in 24 hours till Wednesday morning, showing an alarming sign of deterioration in the pandemic situation.

With the new figures, the death toll jumped to 13,282 while the death rate stood at 1.59 percent, said a handout of the Directorate General of Health Services (DGHS).

Bangladesh’s fight to tackle the second wave of coronavirus has become tougher after the detection of the Delta variant of the virus in different parts of the country.

The higher infection rate in frontier districts and limited capacities in district hospitals have become a challenge amid the worsening situation.

The total caseload reached 8,37,247 with the new cases while the daily infection rate climbed to 16.62% in the 24-hour period.

However, the overall positivity rate stood at 13.41%.

The daily positivity rate was 14.27% on Tuesday and 14.80% on Monday.

Among the deceased, 36 were men and 24 women.

Of them, three were between 11-20 years of age, one was between 21-30, seven between 31-40, 10 between 41-50, 16 between 51-60 and 23 were above 60 years’ old, according to the handout.

Besides, eight of them were from Dhaka division, another eight from Chattogram, 17 from Rajshahi, 14 from Khulna, six from Sylhet, four from Rangpur and three from Mymensingh divisions.

The numbers were found after testing a total of 23,807 samples across the country.

Besides, 2,679 Covid-19 patients recovered in the last 24 hours.

The total number of recoveries now stands at 7,73,752, while the recovery rate at 92.42%.

Lockdown extended

The government has extended the ongoing countrywide lockdown till 15 July as the Covid-19 situation continues to worsen in the country.

However, all government, semi-government, autonomous private offices, banks and financial institutions will remain open maintaining health protocols.

Biotech vaccine to get go-ahead

The National Research Ethics Committee of Bangladesh Medical Research Council (BMRC) on Wednesday decided to approve Globe Biotech’s Covid-19 vaccine, Bangavax, for human trials.

Globe Biotech will get the final nod on conducting clinical trials on humans only after meeting some conditions set by the BMRC, its director Prof Dr Ruhul Amin said this after a virtual meeting.

Bangladesh to set up international vaccine institute

Prime Minister Sheikh Hasina on Wednesday said the government is going to set up an international vaccine institute to produce vaccines, including the Covid-19 ones, in Bangladesh.

She said the government will sign an agreement with South Korea to set up the vaccine institute and the issues relating to ratification, accession and approval of the agreement by the Cabinet are under process.

The Prime Minister said the government has taken an initiative to produce Covid-19 vaccines in the country alongside collection from foreign sources to check the Covid-19 pandemic in the country.

Hasina said government-to-government (G2G) negotiations are underway with the countries that have developed vaccines for transferring technology to this end.

14 die in Khulna, 17 in Rajshahi

Khulna continues to be one of the hardest hit frontier districts as 14 more people died of coronavirus in the district, according to the DGHS handout.

Besides, 139 patients are currently undergoing treatment at Khulna Corona Dedicated Hospital, said Dr Suhash Ranjan Haldar, the nodal person for the corona unit.

Of them, 70 people are receiving treatment in the red zone of the hospital, 21 in the yellow zone, 20 in ICU (intensive care unit), and 28 in HDU (high deficiency unit), said Dr Suhash.

In Rajshahi, 17 more died of Covid-19 in the last 24 hours, the highest in the country during the period.

Meanwhile , director of Rajshahi Medical College and Hospital (RMCH) Brigadier General Shamim Yeazdani on Wednesday told UNB that as many as 48 people have been admitted to the corona unit of the hospital during the time.

Currently, some 344 people are undergoing treatment at the hospital against its capacity of 305 beds in the corona unit.

To deal with the pressure of Covid patients, the hospital authorities have added 34 beds, including two ICU beds, to the hospital’s existing capacity, he said.

Besides, a letter has been sent to the Department of Health Services to send 15 more physicians to the hospital. Some 15 doctors have joined the hospital in the past week.

Test at home

The district administration of Bagerhat has introduced mobile Covid testing booths for collecting swab samples at the doorsteps of people.

Sheikh Sarhan Naser Tonmoy, Bagerhat-2 MP, took the initiative, following a sudden surge in Covid-19 cases in the district.

To avail of the opportunity, people have to make a call on the hotline numbers — 01920-922229 and 01400-305405.

Source: United News of Bangladesh

Biotech’s Covid vaccine to get conditional approval for human trials: BMRC

The National Research Ethics Committee of Bangladesh Medical Research Council (BMRC) on Wednesday decided to approve Globe Biotech’s Covid-19 vaccine, Bangavax, for human trials.

Globe Biotech will get the final nod on conducting clinical trials on humans only after meeting some conditions set by the BMRC, its director Prof Dr Ruhul Amin said this after a virtual meeting.

On January 17, Globe Biotech, the only Bangladeshi company trying to develop a Covid-19 vaccine, submitted a protocol to the BMRC for ethical approval to conduct Bangavax’s clinical trials.

Vaccination drive in Bangladesh

Bangladesh, the prime recipient of Oxford-AstraZeneca vaccines, suspended the registration for Covid-19 vaccination due to jab shortage amid a delay in the arrival of shipments from India.

However, Health Minister Zahid Maleque on Tuesday announced that administering of Sinopharm and Pfizer vaccine doses will begin on June 19.

Some 4,257,499 people got the second dose of AstraZeneca vaccine while the number is 58,20,015 for the first one.

Besides, the total number of people receiving their first jab of Chinese Sinopharm vaccine is 2,162.

The health minister earlier said Pfizer vaccine shots will be given at four centres in Dhaka to those who have already registered.

The Directorate General of Drug Administration (DGDA) on Tuesday approved Janssen Covid-19 vaccine for emergency use in the country.

This is the sixth Covid-19 vaccine to get DGDA nod for emergency use, but the first single-dose jab approved in the country.

The other approved vaccines are: Covishield produced by Serum Institute of India, Sputnik V of Generium Joint Stock Company of Russia, Sinopharm from Beijing Institute of Biological Products Co. Ltd of China, Pfizer vaccine manufactured by Pfizer Manufacturing Belgium NV, and Coronavac produced by Sinovac Life Sciences Ltd of China.

Vaccine procurement update

Bangladesh will soon receive 10 lakh and 800 doses of AstraZeneca vaccine soon under COVAX facility, said Foreign Minister Dr AK Abdul Momen on Friday.

Bangladesh Ambassador to the US conveyed the message of this development to the Foreign Minister.

Bangladesh, earlier sought 2 million doses of AstraZeneca vaccine doses from the US for addressing Bangladesh’s immediate needs but the US is yet to reply on that particular request.

Meanwhile, the second consignment of the Sinopharm vaccine, amounting to some 600,000 doses, arrived here on Sunday as a gift from the Chinese government.

Bangladesh has also received 100,620 doses of the Pfizer Covid-19 vaccine on June 1.

Source: United News of Bangladesh

Novavax: Large study finds COVID-19 shot about 90% effective

Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate for doses.

The two-shot vaccine was about 90% effective overall, and preliminary data showed it was safe, the American company said. That would put the vaccine about on par with Pfizer’s and Moderna’s.

While demand for COVID-19 shots in the U.S. has dropped off dramatically and the country has more than enough doses to go around, the need for more vaccines around the world remains critical. The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting supplies in poor parts of the world.

That help is still months away, however. The company, which has been plagued by raw-material shortages that have hampered production, said it plans to seek authorization for the shots in the U.S., Europe and elsewhere by the end of September and will be able to produce up to 100 million doses a month by then.

“Many of our first doses will go to … low- and middle-income countries, and that was the goal to begin with,” Novavax CEO Stanley Erck said.

While more than half of the U.S. population has had at least one vaccine dose, less than 1% of people in the developing world have had one shot, according to a data collection effort run in part by the University of Oxford.

The Novavax shot stands to become the fifth Western-developed COVID-19 vaccine to win clearance. The Pfizer, Moderna and Johnson & Johnson vaccines are already authorized for use in the U.S. and Europe. Europe also uses AstraZeneca’s formula.

Novavax’s study involved nearly 30,000 people ages 18 and up. Two-thirds received two doses of the vaccine, three weeks apart, and the rest got dummy shots. Nearly half the volunteers were Black, Hispanic, Asian American or Native American, and 6% of participants were in Mexico. Altogether, 37% had health problems that made them high risk, and 13% were 65 or older.

There were 77 cases of COVID-19 — 14 in the group that got the vaccine, the rest in volunteers who received the dummy shots. None in the vaccine group had moderate or severe disease, compared with 14 in the placebo group. One person in that group died.

The vaccine was similarly effective against several variants, including the one first detected in Britain that is now dominant in the U.S., and in high-risk populations, including the elderly, people with other health problems and front-line workers in hospitals and meatpacking plants.

“These consistent results provide much confidence in the use of this vaccine for the global population,” said Dr. Paul Heath, director of the Vaccine Institute at the University of London and St. George’s Hospital.

Side effects were mostly mild — tenderness and pain at the injection site. There were no reports of unusual blood clots or heart problems, Erck said.

A study underway in Britain is testing which of several vaccines, including Novavax’s, works best as a booster shot for people who received the Pfizer or AstraZeneca formula. Industry analyst Kelechi Chikere said the Novavax shot could become a “universal booster” because of its high effectiveness and mild side effects.

Novavax reported the results in a news release and plans to publish them in a medical journal, where they will be vetted by independent experts. The Gaithersburg, Maryland-based company previously released findings from smaller studies in Britain and South Africa.

COVID-19 vaccines train the body to recognize the coronavirus, especially the spike protein that coats it, and get ready to fight the virus off. The Novavax vaccine is made with lab-grown copies of that protein. That’s different from some of the other vaccines now widely used, which include genetic instructions for the body to make its own spike protein.

The Novavax vaccine can be stored in standard refrigerators, making it easier to distribute.

As for the shortages that delayed manufacturing, Erck said those were due to restrictions on shipments from other countries.

“That’s opening up,” he said, adding that Novavax now has weeks’ worth of needed materials in its factories, up from just one week.

The company has committed to supplying 110 million doses to the U.S. over the next year and a total of 1.1 billion doses to developing countries.

In May, vaccines alliance Gavi, a leader of the U.N.-backed COVAX project to supply shots to poorer countries, announced it signed an agreement to buy 350 million doses of Novavax’s formula. COVAX is facing a critical shortage of vaccines after its biggest supplier in India suspended exports until the end of the year.

Novavax has been working on developing vaccines for more than three decades but hasn’t brought one to market. Its coronavirus vaccine work is partly funded by the U.S. government.

Dr. Peter English, a vaccine expert previously with the British Medical Association, called the Novavax results “excellent news.” English said that because vaccine production is complicated, it’s crucial to have as many shots as possible.

“Any minor imperfection in the production plant can shut down the production for days or weeks,” he said in a statement. “The more different manufacturers we have producing vaccine, the more likely it is we will have availability of vaccines.”

He said it was also encouraging news that Novavax would be able to adapt its vaccine to any potentially worrying variants in the future if necessary.

Source: United News of Bangladesh

Soaring e-waste affecting health of millions of children: WHO

Effective and binding action is urgently required to protect the millions of children, adolescents and expectant mothers worldwide whose health is jeopardized by the informal processing of discarded electrical or electronic devices, says a global report on Tuesday.

“With mounting volumes of production and disposal, the world faces what one recent international forum described as a mounting “tsunami of e-waste”, putting lives and health at risk.” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

In the same way the world has rallied to protect the seas and their ecosystems from plastic and microplastic pollution, he said, they need to rally to protect their most valuable resource –the health of their children – from the growing threat of e-waste.

As many as 12.9 million women are working in the informal waste sector, which potentially exposes them to toxic e-waste and puts them and their unborn children at risk, according to the new ground-breaking report from the World Health Organization: Children and Digital Dumpsites.

Meanwhile more than 18 million children and adolescents, some as young as 5 years of age, are actively engaged in the informal industrial sector, of which waste processing is a sub-sector.

Children are often engaged by parents or caregivers in e-waste recycling because their small hands are more dexterous than those of adults.

Other children live, go to school and play near e-waste recycling centres where high levels of toxic chemicals, mostly lead and mercury, can damage their intellectual abilities

Children exposed to e-waste are particularly vulnerable to the toxic chemicals they contain due to their smaller size, less developed organs and rapid rate of growth and development.

They absorb more pollutants relative to their size and are less able to metabolize or eradicate toxic substances from their bodies.

Impact of e-waste on human health

Workers, aiming to recover valuable materials such as copper and gold, are at risk of exposure to over 1,000 harmful substances, including lead, mercury, nickel, brominated flame retardants and polycyclic aromatic hydrocarbons (PAHs).

For an expectant mother, exposure to toxic e-waste can affect the health and development of her unborn child for the rest of its life.

Potential adverse health effects include negative birth outcomes, such as stillbirth and premature births, as well as low birth weight and length.

Exposure to lead from e-waste recycling activities has been associated with significantly reduced neonatal behavioural neurological assessment scores, increased rates of attention deficit/hyperactivity disorder (ADHD), behavioural problems, changes in child temperament, sensory integration difficulties, and reduced cognitive and language scores.

Other adverse child health impacts linked to e-waste include changes in lung function, respiratory and respiratory effects, DNA damage, impaired thyroid function and increased risk of some chronic diseases later in life, such as cancer and cardiovascular disease.

“A child who eats just one chicken egg from Agbogbloshie, a waste site in Ghana, will absorb 220 times the European Food Safety Authority daily limit for intake of chlorinated dioxins,” said Marie-Noel Brune Drisse, the lead WHO author on the report.

“Improper e-waste management is the cause. This is a rising issue that many countries do not recognize yet as a health problem. If they do not act now, its impacts will have a devastating health effect on children and lay a heavy burden on the health sector in the years to come.”

A rapidly escalating problem

E-waste volumes are surging globally.

According to the Global E-waste Statistics Partnership (GESP), they grew by 21% in the five years up to 2019, when 53.6 million metric tonnes of e-waste were generated.

For perspective, last year’s e-waste weighed as much as 350 cruise ships placed end to end to form a line 125km long.

This growth is projected to continue as the use of computers, mobile phones and other electronics continues to expand, alongside their rapid obsolescence.

Only 17.4% of e-waste produced in 2019 reached formal management or recycling facilities, according to the most recent GESP estimates, the rest was illegally dumped, overwhelmingly in low- or middle-income countries, where it is recycled by informal workers.

Appropriate collection and recycling of e-waste is key to protect the environment and reduce climate emissions. In 2019, the GESP found that the 17.4% of e-waste that was collected and appropriately recycled prevented as much as 15 million tonnes of carbon dioxide equivalents from being released into the environment.

Call to Action

Children and Digital Dumpsites called for effective and binding action by exporters, importers and governments to ensure environmentally sound disposal of e-waste and the health and safety of workers, their families and communities; to monitor e-waste exposure and health outcomes; to facilitate better reuse of materials; and to encourage the manufacture of more durable electronic and electrical equipment.

It also called on the health community to take action to reduce the adverse health effects from e-waste, by building health sector capacity to diagnose, monitor and prevent toxic exposure among children and women, raising awareness of the potential co-benefits of more responsible recycling, working with affected communities and advocating for better data and health research on the health risks faced by informal e-waste workers.

“Children and adolescents have the right to grow and learn in a healthy environment, and exposure to electrical and electronic waste and its many toxic components unquestionably impacts that right,” said Dr Maria Neira, Director, Department of Environment, Climate Change and Health, at the WHO.

“The health sector can play a role by providing leadership and advocacy, conducting research, influencing policy-makers, engaging communities, and reaching out to other sectors to demand that health concerns be made central to e-waste policies.”

A significant proportion of e-waste produced every year is exported from high-income countries to low- and middle-income countries, where there may be a lack of regulation, or where regulation does exist, it may be poorly enforced.

Here, e-waste is dismantled, recycled and refurbished in environments where infrastructure, training and environmental and health safeguards may be non-existent or poorly adhered to.

This places e-waste workers, their families and communities in greater danger of adverse health effects from e-waste recycling.

The report was produced with the input and support of the E-Waste Coalition, a group of 10 UN agencies and international organizations, including the WHO, who have come together to increase collaboration, build partnerships and more efficiently provide support to Member States to address the e-waste challenge.

Source: United News of Bangladesh

Global Covid cases top 176 million

Notwithstanding a drop in the number of fresh cases in several countries, the global Covid-19 caseload surged past 176 million on Tuesday.

The total Covid case count and fatalities currently stand at 176,200,581 and 3,808, 883, respectively, as per the data compiled by Johns Hopkins University (JHU).

A total of 2,371,180,270 doses of vaccine have been administered to date, according to the university.

The US, which is the world’s worst-hit country in terms of cases and deaths, has recorded 33,473,180 cases with 599,928 deaths to date.

Brazil has the world’s second-highest Covid-19 death toll, after the United States, and the third-largest caseload, following the United States and India.

So far, the South American country has registered 488,228 deaths, with a record number of 827 new cases in 24 hours till Monday morning.

A total of 39,846 new infections were detected during the period, raising the nationwide caseload to 17,452,612, Brazil’s health ministry said.

India on Monday recorded 70,421 new cases in 24 hours, pushing up the country’s Covid tally to 29,510,410, according to the federal health ministry.

Besides, 3,921 Covid patients have died since Sunday morning, taking the death toll to 374,305.

India has been recording less than one lakh cases for the past few days.

Situation in Bangladesh

Amid a desperate bid to procure vaccines for all, Bangladesh on Monday reported 54 fresh coronavirus-related deaths and 3,050 new cases in 24 hours — both record figures in a month.

The country last recorded 56 deaths on May 9 and a record 3,031 cases on April 27.

With the new numbers, the country’s total caseload and deaths stood at 8,29,972 and 13,172, respectively, the Directorate General of Health Services said on Tuesday.

Vaccination Drive

So far, four vaccines – Oxford-AstraZeneca (Covishield), Sputnik-V, Sinopharm, and Pfizer-BioNTech – have got the approval for emergency use in Bangladesh.

The country, the prime recipient of Oxford-AstraZeneca vaccines, has suspended the registration for Covid-19 jabs due to vaccine shortage amid a delay in the arrival of shipments from India.

Some 42,532,526 people have so far got the second dose of this vaccine, while the number is 58,20,015 for the first one.

Bangladesh will start administering Sinopharm and Pfizer vaccine doses from June 19, Health Minister Zahid Maleque has said.

Pfizer vaccine shots will be given at four centres in Dhaka to those who have already registered, he has said.

Source: United News of Bangladesh

RMCH sees 12 more Covid deaths in 24 hrs

Rajshahi Medical College Hospital (RMCH) recorded 12 more deaths from Coronavirus infection in 24 hours until 6 am on Tuesday.

Among them, eight were Covid-19 patients while the rest four died after showing Covid-19 symptoms at the hospital, said director of the hospital Brigadier General Shamim Yeazdani.

Of the deceased, three were from Rajshahi, seven from Chapainawabganj, one each from Natore and Naogaon districts.

A total of 148 people have died of Covid-19 in Rajshahi division in the last 15 days till Tuesday morning as situation is worsening in different border districts.

Shamim Yazdani said 58 people were admitted to the Corona unit of the hospital in 24 hours till Tuesday morning.

Of them, 39 are from Rajshahi, eight from Chapainawabganj, four from Natore, five from Naogaon and two from Kushtia.

Forty-three people were discharged from the hospital after recovery during the period.

Besides, 325 people are undergoing treatment against 273 beds at the Corona unit of the hospital.

Of them, 189 are from Rajshahi, 82 from Chapainawabganj, 17 from Natore, 26 from Naogaon, four from Pabna, six from Kushtia and one from Chuadanga.

However, the hospital authorities are providing treatment after arranging additional beds, said Shamim.

As the coronavirus situation in Rajshahi kept worsening the district administration imposed a strict lockdown from 5pm on June 4 till June 17 midnight.

Source: United News of Bangladesh

Bangladeshi Lyft driver killed in NYC crash

A Bangladeshi-American Lyft driver died after a ‘drunken driver’ struck his vehicle in Queens, New York City on Sunday.

The accident took place at the intersection of Fresh Pond Road and Elliott Avenue in Maspeth.

Authorities identified the victim as Mohammed Hossain, 47, a father of three in Brooklyn, according to local dailies. He had migrated from Bangladesh 12 years ago.

Hossain’s devastated friends and relatives visited the scene of the crash Sunday morning, trying to wrap their head around the sudden loss of the beloved family man.

Hossain supported his wife and their three children in Borough Park, Brooklyn, by driving for Uber and Lyft.

“It’s only when the person you just talked to a few days ago is joking and you’re not there. It doesn’t make sense,” his brother-in-law Rezaul Rahman said.

Rahman says his sister, Hossain’s wife, was contacted after 8 am.

Source: United News of Bangladesh